GAD-7 (General Anxiety Disorder-7)
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Minimal Anxiety0–4
- Mild Anxiety5–9
- Moderate Anxiety10–14
- Severe Anxiety15–21
The GAD-7 (General Anxiety Disorder-7) calculates screening symptom severity, assessing suicide risk, and monitoring psychotherapeutic response. Key inputs include nervous anxious on edge. Scores guide establishing safety containment plans, initiating pharmacotherapy, and scheduling close outpatient psychiatric review. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Measures anxiety severity and screens for generalized anxiety disorder
Clinical Indication
The GAD-7 (General Anxiety Disorder-7) is indicated for bedside clinical practice to support Measures anxiety severity and screens for generalized anxiety disorder. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients undergoing evaluation for mood disorders, anxiety, psychosis, cognitive impairment, or suicidal ideation. Clinical application is indicated across Psychiatric emergency services, inpatient behavioral health units, and outpatient psychiatric clinics.
Limitations & Contraindications
Patient self-report bias, cognitive impairment, or acute intoxication can significantly skew questionnaire scoring.
Clinical Pearls & Action Plan
Standardized clinical rating scales serve as diagnostic adjuncts and cannot substitute for an exhaustive clinical psychiatric interview. Guideline pearl: Score ≥8 may indicate probable generalized anxiety disorder (sensitivity 92%, specificity 76%).
Sum of scores for all 7 items (each scored 0-3 points)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| nervous_anxious_on_edge | integer | Yes | Feeling nervous, anxious, or on edge (over the past 2 weeks) |
| not_able_stop_control_worrying | integer | Yes | Not being able to stop or control worrying (over the past 2 weeks) |
| worrying_too_much_different_things | integer | Yes | Worrying too much about different things (over the past 2 weeks) |
| trouble_relaxing | integer | Yes | Trouble relaxing (over the past 2 weeks) |
| being_so_restless | integer | Yes | Being so restless that it's hard to sit still (over the past 2 weeks) |
| becoming_easily_annoyed_irritable | integer | Yes | Becoming easily annoyed or irritable (over the past 2 weeks) |
| feeling_afraid_something_awful | integer | Yes | Feeling afraid as if something awful might happen (over the past 2 weeks) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–4 | Minimal Anxiety | Minimal anxiety symptoms |
| 5–9 | Mild Anxiety | Mild anxiety symptoms |
| 10–14 | Moderate Anxiety | Moderate anxiety symptoms |
| 15–21 | Severe Anxiety | Severe anxiety symptoms |
Evidence-Based References (EBM)
- Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-7. doi: 10.1001/archinte.166.10.1092.DOI: 10.1001/archinte.166.10.1092
- Löwe B, Decker O, Müller S, et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care. 2008;46(3):266-74. doi: 10.1097/MLR.0b013e318160d093.DOI: 10.1097/MLR.0b013e318160d093
- Plummer F, Manea L, Trepel D, McMillan D. Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis. Gen Hosp Psychiatry. 2016;39:24-31. doi: 10.1016/j.genhosppsych.2015.11.005.DOI: 10.1016/j.genhosppsych.2015.11.005